6 Results for "

ErSO

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "ErSO" in MCE Product Catalog:

Cat. No.: HY-144070
CAS No.: 2768139-76-8
Purity:  99.56%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

ErSO-DFP is an anticipatory unfolded protein response (a-UPR) activator. ErSO-DFP has enhanced selectivity for estrogen receptor alpha-positive (ERα+) cancer cells with a wider selectivity window than ErSO (HY-132247). ErSO-DFP displays antitumor activity against MCF-7 in mice. ErSO-DFP can cross the blood brain barrier .
loading...
    loading...
Cat. No.: HY-132247
CAS No.: 2407860-35-7
Purity:  99.95%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

ErSO is a selective anticipatory unfolded protein response (a-UPR) activator. ErSO acts through ERα to elicit strong and sustained cytotoxic activation of the a-UPR. ErSO can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-153468
CAS No.: 3035547-78-2
Synonyms: TEQ103; Sera2
Research Areas:  

Cancer

ErSO-TFPy (TEQ103) is an ERα+ tumor cell inhibitor with low nanomolar cytotoxic activity against ERα+ breast cancer cells. ErSO-TFPy activates the sodium channel TRPM4, causes an imbalance of intracellular calcium and sodium ions. ErSO-TFPy dysregulates calcium homeostasis in ERα+ tumor cells, triggers the anticipatory unfolded protein response, and induces rapid immune cell-independent necrotic cell death. ErSO-TFPy can be used for the research of estrogen receptor alpha positive breast cancer .
loading...
    loading...
Cat. No.: HY-132247B
CAS No.: 2407860-34-6
Purity:  99.40%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

(S)-ErSO is the dextrorotatory enantiomer of ErSO. (S)-ErSO is inactive in MCF-7 cells (from patent WO2020009958A1, compound (s)-105) .
loading...
    loading...
Cat. No.: HY-132247A
CAS No.: 2407860-40-4
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

(±)-ErSO is the racemate of ErSO. ErSO is a selective anticipatory unfolded protein response (a-UPR) activator .
loading...
    loading...
Cat. No.: HY-144070A
CAS No.: 2768139-73-5
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

(Rac)-ErSO-DFP is a derivative of ErSO-DFP and a selective small molecule Erα biomodulator. (Rac)-ErSO-DFP againsts ERα+ breast cancer (including resistant tumors) by hyperactiving the Erα-dependent a-UPR (extracted from patent WO2022087234A1) .
loading...
    loading...